Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Cell. 2012 Jul 10;22(1):7-8. doi: 10.1016/j.ccr.2012.06.009.

The future of cancer treatment: will it include immunotherapy?

Author information

  • 1Diabetes Center, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA.


Negative immune regulatory pathways inhibit anti-cancer T cell responses, preventing effective immune surveillance. Two clinical trials using monoclonal antibodies that antagonize the PD-1/PD-L1 pathway recently reported regression in several tumor types. In one of these trials, efficacy was linked to the expression of the PD-L1 biomarker on tumor cells.

Copyright © 2012 Elsevier Inc. All rights reserved.

Free full text

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk